Abstract
Trastuzumab is a mainstay chemotherapeutic agent used in the treatment of human epidermal growth factor receptor 2 (HER2)/neu-positive breast cancer t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
